Yes. Olive oil, fish, vegetables, legumes — the diet pattern with the strongest cardiovascular RCT evidence.
The PREDIMED trial remains the strongest RCT evidence for any diet pattern on cardiovascular outcomes.
Our read is Well Supported. The intervention clears a strong evidence base (84/100) with broad agreement among the voices we track (90% consensus). At $120/month and low effort, following a Mediterranean pattern is one of the more defensible moves on this list — the burden of proof has largely been met.
Pulled the public claims about following a Mediterranean pattern from proponents on file (a tracked voice and a tracked voice) and weighed them against the more cautious voices in the field, then cross-checked each against the primary trial and cohort literature and the prevailing clinical guidance. We grade the claim against what the human evidence actually supports, not against how confidently it is stated.
Downside risk on following a Mediterranean pattern is low at sensible doses, but low risk is not no risk: individual response varies, and a low-risk intervention is still only worth it if the benefit is real.
A well-powered trial showing the effect fails to hold up, or new safety surveillance that shifts the risk-benefit, would move this verdict.
The intervention improves the primary outcome at standard doses in healthy adults.
The effect size is large enough to matter clinically, not just statistically.
Mechanistic and trial evidence converge on a real, replicable effect.
The intervention improves the primary outcome at standard doses in healthy adults.
Benefits hold across the populations where it's been tested.
The headline effect shrinks once you account for trial quality.
Confounding and publication bias inflate the apparent benefit.
Most of the support comes from short or small studies.
Animal-model results don't translate to the human protocol being recommended.
Animal-model results don't translate to the human protocol being recommended.